Literature DB >> 10352166

Use of alternative medicine by women with early-stage breast cancer.

H J Burstein1, S Gelber, E Guadagnoli, J C Weeks.   

Abstract

BACKGROUND: We analyzed the use of alternative medicine by women who had received standard therapy for early-stage breast cancer diagnosed between September 1993 and September 1995.
METHODS: A cohort of 480 patients with newly diagnosed early-stage breast cancer was recruited from a Massachusetts statewide cohort of women participating in a study of how women choose treatment for cancer. Alternative medical treatments, conventional therapies, and health-related quality of life were examined.
RESULTS: New use of alternative medicine after surgery for breast cancer was common (reported by 28.1 percent of the women); such use was not associated with choices about standard medical therapies after we controlled for clinical and sociodemographic variables. A total of 10.6 percent of the women had used alternative medicine before they were given a diagnosis of breast cancer. Women who initiated the use of alternative medicine after surgery reported a worse quality of life than women who never used alternative medicine. Mental health scores were similar at base line among women who decided to use alternative medicine and those who did not, but three months after surgery the use of alternative medicine was independently associated with depression, fear of recurrence of cancer, lower scores for mental health and sexual satisfaction, and more physical symptoms as well as symptoms of greater intensity. All groups of women reported improving quality of life one year after surgery.
CONCLUSIONS: Among women with newly diagnosed early-stage breast cancer who had been treated with standard therapies, new use of alternative medicine was a marker of greater psychosocial distress and worse quality of life.

Entities:  

Mesh:

Year:  1999        PMID: 10352166     DOI: 10.1056/NEJM199906033402206

Source DB:  PubMed          Journal:  N Engl J Med        ISSN: 0028-4793            Impact factor:   91.245


  127 in total

1.  Cancer, psychologic factors, and behavior: a complex and controversial relationship.

Authors:  M Markman
Journal:  Curr Oncol Rep       Date:  2000-01       Impact factor: 5.075

2.  Emotional dimensions of chronic disease.

Authors:  J Turner; B Kelly
Journal:  West J Med       Date:  2000-02

Review 3.  Complementary and alternative medicine: what is it all about?

Authors:  E Ernst; A Fugh-Berman
Journal:  Occup Environ Med       Date:  2002-02       Impact factor: 4.402

Review 4.  What the general psychiatrist should know about herbal medicine.

Authors:  E Kenny; P R Muskin; R Brown; P L Gerbarg
Journal:  Curr Psychiatry Rep       Date:  2001-06       Impact factor: 5.285

5.  Complementary and alternative medicine use among cancer survivors: a population-based study.

Authors:  Jun James Mao; Christina Shearer Palmer; Kaitlin Elizabeth Healy; Krupali Desai; Jay Amsterdam
Journal:  J Cancer Surviv       Date:  2010-10-06       Impact factor: 4.442

6.  Complementary and alternative medicines use by Scottish women with breast cancer. What, why and the potential for drug interactions?

Authors:  J S McLay; D Stewart; J George; C Rore; S D Heys
Journal:  Eur J Clin Pharmacol       Date:  2011-12-14       Impact factor: 2.953

7.  Is it time for oncologists to modify their laissez-faire attitude toward alternative/complementary 'drug therapy'?

Authors:  Maurie Markman
Journal:  Curr Oncol Rep       Date:  2004-01       Impact factor: 5.075

8.  Complementary therapies for cancer, more good than harm?

Authors:  Edzard Ernst
Journal:  Wien Klin Wochenschr       Date:  2003-10-31       Impact factor: 1.704

Review 9.  Quality, efficacy and safety of complementary medicines: fashions, facts and the future. Part I. Regulation and quality.

Authors:  Joanne Barnes
Journal:  Br J Clin Pharmacol       Date:  2003-03       Impact factor: 4.335

10.  Complementary and alternative medicine use among men with prostate cancer in 4 ethnic populations.

Authors:  Marion M Lee; Jeffrey S Chang; Bradly Jacobs; Margaret R Wrensch
Journal:  Am J Public Health       Date:  2002-10       Impact factor: 9.308

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.